Biotechnology Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of Medicine – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Omega Therapeutics, Inc. Reports Q1 Loss, Tops Revenue Estimates – Cytokinetics (NASDAQ:CYTK), Omega Therapeutics (NASDAQ:OMGA) Read more
Biotechnology Cytokinetics to Announce First Quarter Results on May 8, 2024 – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 Congress – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific Session – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare Conference – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific Session – Cytokinetics (NASDAQ:CYTK) Read more
Biotechnology Cytokinetics to Participate in March Investor Conferences – Cytokinetics (NASDAQ:CYTK) Read more
